Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The consulting business reported higher revenue and profit, owing in part to the contribution of 株式会社DataStrategy. The healthcare business reported higher revenue and profit, mainly due to the expansion of its medical institution network. Although the nail business benefited from contributions from new stores, it incurred a loss because personnel expenses, depreciation and other costs associated with new store openings placed a burden on earnings. The AI business incurred a loss due to upfront expenses and other costs related to launching the business.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥6,907 million (YoY +554.5%) |
| Operating profit | ¥1,937 million |
| Ordinary income | ¥1,941 million |
| Profit attributable to owners of the parent | ¥1,195 million (YoY +925.8%) |
| Net income per share | ¥2.40 |
| Equity ratio | End of the current fiscal period 68.6 / End of previous period 57.6 |
| Total assets | ¥17,693 million |
| Net assets | ¥12,136 million |
| Cash flows from operating activities | ¥-1,167,356 thousand |
| Cash flows from investing activities | ¥-1,677 thousand |
| Cash flows from financing activities | ¥-338,992 thousand |
| Cash and cash equivalents at end of period | ¥2,744,210 thousand |
| Full-year earnings forecast | Net Sales ¥26,752 million (YoY +72.4%) / Operating profit ¥8,957 million (YoY +459.5%) / Ordinary income ¥9,000 million (YoY +533.6%) / Net income ¥5,820 million |
| Annual Dividend Forecast | ¥1.00 → ¥1.00（0.0%） |
| Segment revenue | Segment Nail business / Net Sales ¥907,303 thousand / Year-on-year (%) 20.2, Segment Consulting business / Net Sales ¥5,102,650 thousand / Year-on-year (%) Not disclosed, Segment Healthcare Business / Net Sales ¥870,544 thousand / Year-on-year (%) 579.8, Segment Investment & Advisory business / Net Sales ¥26,663 thousand / Year-on-year (%) -69.5, Segment AI Business / Net Sales Not disclosed / Year-on-year (%) Not disclosed |
| Segment profit | Segment Nail business / Segment profit ¥-10,481 thousand / Year-on-year (%) Not disclosed, Segment Consulting business / Segment profit ¥1,563,930 thousand / Year-on-year (%) Not disclosed, Segment Healthcare Business / Segment profit ¥538,629 thousand / Year-on-year (%) 542.9, Segment Investment & Advisory business / Segment profit ¥-32,438 thousand / Year-on-year (%) Not disclosed, Segment AI Business / Segment profit ¥-92,412 thousand / Year-on-year (%) Not disclosed |
| Depreciation and amortization | ¥94,986 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | 0 additions (company name: —), 0 exclusions (company name: —) |
| Material subsequent events | On 2 July 2026, AXEL MARK INC. became a consolidated subsidiary through the acquisition of 68.91% of its voting equity interests. The acquisition consideration was ¥900 million. In addition, the sale of the Company's held cryptoassets was completed on 10 August 2026, and the Company expects to recognize a ¥298 million loss on the sale in the second quarter of the fiscal year ending March 2027. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 509,156,000 |
| Treasury Shares at Period-End | 10,520,100 |
| Factors Behind Changes in Business Performance | The consulting business reported higher revenue and profit, owing in part to the contribution of 株式会社DataStrategy. The healthcare business reported higher revenue and profit, mainly due to the expansion of its medical institution network. Although the nail business benefited from contributions from new stores, it incurred a loss because personnel expenses, depreciation and other costs associated with new store openings placed a burden on earnings. The AI business incurred a loss due to upfront expenses and other costs related to launching the business. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company proceeded to monetize the expanded business platform created through diversification of its business portfolio. The consulting business reported higher revenue and profit, owing in part to the contribution of 株式会社DataStrategy, which became a consolidated subsidiary in the previous fiscal year. The healthcare business also reported higher revenue and profit, mainly due to the expansion of its medical institution network. Although the nail business benefited from contributions from new stores, personnel expenses, depreciation and other costs associated with new store openings weighed on profit. The AI business incurred a loss due to upfront expenses and other costs related to launching the business.